NovAseptic was founded in Sweden in 1993 and has been part of Merck Millipore since 2005. With their wide range of mixers, valves and connectors for the pharmaceutical and biotechnology industries, product safety, quality, strength and purity are improved. NovAseptic mixers, valves and connectors have a reliable and proven aseptic performance within the pharmaceutical and biotechnology industries. The Life Science business in Merck KGaA, Darmstadt, Germany, operating as MilliporeSigma in the United States and Canada, has approximately 22,000 employees and 59 manufacturing sites worldwide with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA completed its acquisition of Sigma-Aldrich in November 2015, thus achieving a leading role within the global life-science industry.
A leading science and technology company, Merck KGaA operates across healthcare, life science and performance materials. Around 58,000 employees work to make a positive difference to the lives of millions of people every day by creating more life-affirming and sustainable ways of living. From advanced genetic engineering and the discovery of unique ways to treat the most challenging diseases to enabling the intelligence of devices - the company is everywhere. In 2019, Merck KGaA sold for €16.2 billion in 66 countries. The company has the global rights to the name and trademark "Merck" internationally. The only exceptions are the USA and Canada, where the business sectors Merck KGaA, Darmstadt, Germany operate as EMD Serono in the healthcare sector, MilliporeSigma in the life sciences and EMD Performance Materials. Since its foundation in 1668, scientific research and responsible entrepreneurship have been the key to the company's technological and scientific progress. To this day, the founding family remains the majority owner of the listed company.
